Has Kenneth Mayer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,883 in general payments to Kenneth Mayer, MD across 523 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kenneth Mayer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kenneth Mayer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kenneth Mayer, MD

Family Medicine · Jacksonville, FLNPI 1669449229

Payments from drug & device makers

$8,883in general payments, 2019–2025

Across 523 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Pfizer$858
Boehringer Ingelheim$789
Merck$624
Novo Nordisk$623
GSK$560
plus $4K from 37 others

What the payments were for

Food & beverage$8,79399%
Education$891%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	60	$1,019
Pfizer	56	$858
Boehringer Ingelheim	45	$789
Merck	36	$624
Novo Nordisk	38	$623
GSK	32	$560
AbbVie(2 entities)	37	$555
Lilly USA, LLC	40	$497
Amgen(2 entities)	24	$483
Sanofi-aventis U.S. LLC	20	$359
Takeda Pharmaceuticals U.S.A., Inc.	18	$331
Dexcom, Inc.	9	$237
Abbott	12	$229
Novartis	12	$190
Johnson & Johnson(2 entities)	10	$169
Astellas Pharma US Inc	4	$142
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	9	$133
Kowa Pharmaceuticals America, Inc.	8	$111
Sanofi Pasteur Inc.	7	$105
Exact Sciences	5	$104
Bayer	6	$88
Amarin Pharma, Inc.	4	$74
Regeneron	1	$64
Biohaven Pharmaceutical Holding Company Ltd.	2	$54
Phathom Pharmaceuticals, Inc.	2	$52
Teva Pharmaceuticals USA, Inc.	3	$45
Bausch Health US, LLC	2	$36
Daiichi Sankyo Inc.	2	$34
Boston Scientific	2	$30
Gilead	2	$29
Vivus LLC	2	$27
Idorsia Pharmaceuticals US Inc	2	$26
Xeris Pharmaceuticals, Inc.	1	$25
Ironshore Pharmaceuticals Inc.	1	$23
Biohaven Pharmaceuticals, Inc.	1	$23
Dynavax Technologies Corporation	1	$20
Nestle Healthcare Nutrition Inc.	1	$20
Sunovion Pharmaceuticals Inc.	1	$19
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$19
Supernus Pharmaceuticals, Inc.	1	$18
Dermira, Inc.	1	$14
Eisai Inc.	1	$14
Assertio Therapeutics, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CAPVAXIVE$126

How this compares

$8,883 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$11,030

Medicare patients

Services billed

128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Montelukast Sodium	44	$738
Atorvastatin Calcium	31	$296
Omeprazole	14	$202
Rosuvastatin Calcium	11	$158
Losartan Potassium	16	$151
Lisinopril	22	$143
Fluticasone Propionate	11	$118
Amlodipine Besylate	18	$63
Ciprofloxacin Hcl	12	$61
Alprazolam	13	$52

Paid to pharmacies, not to this prescriber.

Other family medicine in Jacksonville

Jeffry JacqmeinJacksonville$8.7M
Herman DowneyJacksonville$4.1M
Hugh ColemanDaytona Beach$115.5M
Alexander WhiteDaytona Beach$69.7M
Ronald SurowitzJupiter$38.3M
Bruce RankinDeland$36.7M
Keila HooverMiami$33.7M
John NardandreaOcala$30.8M
Jorge CasoMiami$22.6M
Sharrell CooperPalm Coast$16.9M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →